chr8-89933828-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002485.5(NBN):​c.*1754T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.322 in 232,162 control chromosomes in the GnomAD database, including 12,096 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 7671 hom., cov: 31)
Exomes 𝑓: 0.33 ( 4425 hom. )

Consequence

NBN
NM_002485.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.468

Publications

21 publications found
Variant links:
Genes affected
NBN (HGNC:7652): (nibrin) Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
NBN Gene-Disease associations (from GenCC):
  • Nijmegen breakage syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • idiopathic aplastic anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 8-89933828-A-G is Benign according to our data. Variant chr8-89933828-A-G is described in ClinVar as [Benign]. Clinvar id is 363896.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.391 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NBNNM_002485.5 linkc.*1754T>C 3_prime_UTR_variant Exon 16 of 16 ENST00000265433.8 NP_002476.2 O60934

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NBNENST00000265433.8 linkc.*1754T>C 3_prime_UTR_variant Exon 16 of 16 1 NM_002485.5 ENSP00000265433.4 O60934

Frequencies

GnomAD3 genomes
AF:
0.317
AC:
48195
AN:
151926
Hom.:
7661
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.297
Gnomad AMI
AF:
0.338
Gnomad AMR
AF:
0.292
Gnomad ASJ
AF:
0.261
Gnomad EAS
AF:
0.407
Gnomad SAS
AF:
0.318
Gnomad FIN
AF:
0.305
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.333
Gnomad OTH
AF:
0.308
GnomAD4 exome
AF:
0.332
AC:
26633
AN:
80122
Hom.:
4425
Cov.:
0
AF XY:
0.332
AC XY:
12251
AN XY:
36874
show subpopulations
African (AFR)
AF:
0.296
AC:
1143
AN:
3868
American (AMR)
AF:
0.301
AC:
750
AN:
2488
Ashkenazi Jewish (ASJ)
AF:
0.272
AC:
1385
AN:
5090
East Asian (EAS)
AF:
0.410
AC:
4579
AN:
11172
South Asian (SAS)
AF:
0.277
AC:
192
AN:
692
European-Finnish (FIN)
AF:
0.397
AC:
23
AN:
58
Middle Eastern (MID)
AF:
0.263
AC:
128
AN:
486
European-Non Finnish (NFE)
AF:
0.329
AC:
16284
AN:
49552
Other (OTH)
AF:
0.320
AC:
2149
AN:
6716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
932
1864
2796
3728
4660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.317
AC:
48232
AN:
152040
Hom.:
7671
Cov.:
31
AF XY:
0.316
AC XY:
23503
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.297
AC:
12312
AN:
41462
American (AMR)
AF:
0.292
AC:
4467
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.261
AC:
904
AN:
3464
East Asian (EAS)
AF:
0.406
AC:
2101
AN:
5178
South Asian (SAS)
AF:
0.320
AC:
1541
AN:
4812
European-Finnish (FIN)
AF:
0.305
AC:
3226
AN:
10568
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.333
AC:
22647
AN:
67962
Other (OTH)
AF:
0.306
AC:
644
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1703
3405
5108
6810
8513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.319
Hom.:
10082
Bravo
AF:
0.312
Asia WGS
AF:
0.309
AC:
1075
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Microcephaly, normal intelligence and immunodeficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.0
DANN
Benign
0.40
PhyloP100
-0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9995; hg19: chr8-90946056; API